Replies to post #8920 on BioAmber Inc fka BIOAQ

[TradeReaper]

Stayed. Likely the reason they filed for bk anyway. Next.

[DonateLove]

Perhaps depreciation or a lien payment. The Plant market value was calculated last February by a Canadian firm and presented in recent court documents. After converting into US dollar and using the most recent docs (June13 + Nexant) I get:

Plant $53.8 low – $73 premium Averaged at 63.4
Inventory $2.4
Cash $0.4
A/R $1.7

Total Assets: $67.9
Debt: $51
Equity: $16.9
Conservative Value per Share: $0.13


Added buyout deal consideration:
Patents $4
1yr Forward Revenue $20
Plant at $70 premium due to bidding war

Total Assets: $98.5
Equity: $47.5
Premium Value per Share: $0.37

I won’t include the NOL because that would limit bidders to agree on a 49% merger instead. Account receivables can increase from recent succinct acid sales.

Others claim a $1.20 book value per share which could happen if there is a bid war and the buyer pays a premium and another year of revenues forward.

Since people found out that the company would end up with a larger equity than just liquidating it, traders are trying to close the upside gap before the buyout closes by the end of July.